Arrangement of the ILT gene cluster: a common null allele of the ILT6 gene results from a 6.7-kbp deletion
- PMID:11169408
- DOI: 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y
Arrangement of the ILT gene cluster: a common null allele of the ILT6 gene results from a 6.7-kbp deletion
Abstract
The leukocyte receptor cluster (LRC) is a highly polymorphic region of human chromosome 19q13.4 that encompasses at least 24 members of the immunoglobulin superfamily (Ig-SF). The centromeric end of the LRC contains eight Ig-SF loci, namely LAIR1 and seven ILT genes. All ILT genes conform to prototypic ILT gene structures. ILT6 is the only member of the ILT family that lacks a transmembrane and cytoplasmic domain. Close examination of the ILT6 genomic sequence reveals high similarity of this locus with the organization of activating ILT genes. However, the ILT6 transcript runs through the putative splice site of exon 8 that encodes for an extracellular stalk region, leading to a premature in-frame stop codon. Downstream of exon 8 are three pseudo exons that are not included in any of the known ILT6 transcripts, but share high homology to the equivalent region in activating ILT loci, suggesting that these genes have evolved from a common ancestral sequence. Comparison of two haplotypes over this region revealed a remarkable polymorphism with respect to the ILT6 gene which lacks exons 1-7 in one allele, reminiscent of the presence/absence variation displayed by the closely related and genetically linked KIR loci. Detailed sequence analysis of the two LAIR/ILT clusters suggests that the two complexes may have evolved from an inverted duplication.
Similar articles
- The genomic context of natural killer receptor extended gene families.Trowsdale J, Barten R, Haude A, Stewart CA, Beck S, Wilson MJ.Trowsdale J, et al.Immunol Rev. 2001 Jun;181:20-38. doi: 10.1034/j.1600-065x.2001.1810102.x.Immunol Rev. 2001.PMID:11513141Review.
- Extensive gene duplications and a large inversion characterize the human leukocyte receptor cluster.Wende H, Volz A, Ziegler A.Wende H, et al.Immunogenetics. 2000 Jul;51(8-9):703-13. doi: 10.1007/s002510000187.Immunogenetics. 2000.PMID:10941842
- Isotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complex.Torkar M, Norgate Z, Colonna M, Trowsdale J, Wilson MJ.Torkar M, et al.Eur J Immunol. 1998 Dec;28(12):3959-67. doi: 10.1002/(SICI)1521-4141(199812)28:12<3959::AID-IMMU3959>3.0.CO;2-2.Eur J Immunol. 1998.PMID:9862332
- Conserved organization of the ILT/LIR gene family within the polymorphic human leukocyte receptor complex.Young NT, Canavez F, Uhrberg M, Shum BP, Parham P.Young NT, et al.Immunogenetics. 2001 May-Jun;53(4):270-8. doi: 10.1007/s002510100332.Immunogenetics. 2001.PMID:11491530
- Genesis of the ILT/LIR/MIR clusters within the human leukocyte receptor complex.Volz A, Wende H, Laun K, Ziegler A.Volz A, et al.Immunol Rev. 2001 Jun;181:39-51. doi: 10.1034/j.1600-065x.2001.1810103.x.Immunol Rev. 2001.PMID:11513150Review.
Cited by
- Generation and characterization of two novel monoclonal antibodies produced against human TLT-2 molecule.Xu JC, Gao F, Fu FQ, Chen YJ, Xu P, Zhou B, Zhang XG.Xu JC, et al.Monoclon Antib Immunodiagn Immunother. 2013 Jun;32(3):216-23. doi: 10.1089/mab.2012.0086.Monoclon Antib Immunodiagn Immunother. 2013.PMID:23750481Free PMC article.
- Comparative genomics of natural killer cell receptor gene clusters.Kelley J, Walter L, Trowsdale J.Kelley J, et al.PLoS Genet. 2005 Aug;1(2):129-39. doi: 10.1371/journal.pgen.0010027.PLoS Genet. 2005.PMID:16132082Free PMC article.
- The expression and clinical significance of different forms of LILRA3 in systemic lupus erythematosus.Du Y, Sun F, Zhou M, Wu X, Sun W, Jiang Y, Cheng Q, Chen X, Wu H, Xue J.Du Y, et al.Clin Rheumatol. 2019 Nov;38(11):3099-3107. doi: 10.1007/s10067-019-04624-z. Epub 2019 Jun 17.Clin Rheumatol. 2019.PMID:31209706
- The Genomic Organization of theLILR Region Remained Largely Conserved Throughout Primate Evolution: Implications for Health And Disease.Storm L, Bruijnesteijn J, de Groot NG, Bontrop RE.Storm L, et al.Front Immunol. 2021 Oct 19;12:716289. doi: 10.3389/fimmu.2021.716289. eCollection 2021.Front Immunol. 2021.PMID:34737739Free PMC article.Review.
- Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility.An H, Lim C, Guillemin GJ, Vollmer-Conna U, Rawlinson W, Bryant K, Tedla N.An H, et al.PLoS One. 2016 Feb 12;11(2):e0149200. doi: 10.1371/journal.pone.0149200. eCollection 2016.PLoS One. 2016.PMID:26871720Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources